Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.
Brenner AJ, Peters KB, Vredenburgh J, Bokstein F, Blumenthal DT, Yust-Katz S, Peretz I, Oberman B, Freedman LS, Ellingson BM, Cloughesy TF, Sher N, Cohen YC, Lowenton-Spier N, Rachmilewitz Minei T, Yakov N, Mendel I, Breitbart E, Wen PY.
Brenner AJ, et al. Among authors: oberman b.
Neuro Oncol. 2020 May 15;22(5):694-704. doi: 10.1093/neuonc/noz231.
Neuro Oncol. 2020.
PMID: 31844886
Free PMC article.
Clinical Trial.